About the Study
Previous research studies suggested that escitalopram (an antidepressant also known as Lexapro or Cipralex) can improve asthma symptoms in people who were depressed. The purpose of this study is to determine if escitalopram (the study drug) is associated with fewer asthma attacks requiring oral corticosteroid use than placebo (inactive ingredient) in people who have not been diagnosed with depression who have moderate to severe asthma with frequent asthma exacerbation.
We are currently enrolling adults who meet the following criteria:
- 18-75 years of age
- Diagnosed with moderate to severe asthma
- English or Spanish speaking
- Had 3 or more asthma flares in the past year
- Currently use a medium to high dose ICS & LABA inhaler
This study includes:
- 26-week study with monthly visits (9 total visits)
- Study medication or placebo
- Assessments & questionnaires
- Pulmonary function testing
- Blood draw
- Up to $740 compensation if all visits attended